Oireachtas Joint and Select Committees

Wednesday, 12 July 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion

9:00 am

Photo of Kate O'ConnellKate O'Connell (Dublin Bay South, Fine Gael) | Oireachtas source

Professor Barry referred to the complexity of the dossiers that the NCPE was receiving. Is there a set standard operating procedure by which companies submit information or does the NCPE just get a large box of stuff and has to root through it? If the approach is not streamlined, one can see how it might clog up the system.

Mr. Hennessy stated that some companies were not prepared to negotiate. Is that company specific or indication specific? Do some companies not play ball or do they view the Irish market as not being worth their while to reduce prices in respect of certain illnesses?

Comments

No comments

Log in or join to post a public comment.